Basilea Pharmaceutica AG provided earnings guidance for the year 2024. For the year, the company's total revenue is expected to amount to approximately CHF 183 million. The company expects a more than 50% increase in operating profit to approximately CHF 30 million and a more than doubling of net profit to approximately CHF 25 million.